Vardenafil Hydrochloride | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Vardenafil Hydrochloride
Health Canada Patents

Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

Contact Supplier

Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

Contact Supplier

HealthTech BioActives, leading globally in Flavonoids and Vitamin B12 Derivatives.

Contact Supplier

Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

Contact Supplier

Aspen API. More than just an API™

Contact Supplier

FAMAR CDMO- From early development to commercial manufacturing.

Contact Supplier

Vardenafil Hydrochloride

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

41 API Suppliers, 6 USDMF, 5 CEP/COS, 2 JDMF, 2 EU WC, 2 KDMF, 23 NDC API, 22 Listed Suppliers, $ API Reference Price

41 API Suppliers
6 USDMF
5 CEP/COS
2 JDMF
2 EU WC
2 KDMF
23 NDC API
22 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

9 Drugs in Development

9 Drugs in Development

INTERMEDIATES

4 Intermediate Suppliers

4 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

215 FDF Dossiers, 32 FDA Orange Book, 152 Europe, 6 Canada, 5 South Africa, 20 Listed Dossiers

215 FDF Dossiers
32 FDA Orange Book
152 Europe
6 Canada
5 South Africa
20 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET, ORALLY DISINTEGRATING;ORAL - 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 2.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 20MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, ORALLY DISINTEGRATING;ORAL - 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - EQ 10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - EQ 2.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - EQ 20MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

3 Rochem International Inc, 15 SPI Pharma, 5 DKSH, 4 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 1 ACG Worldwide, 3 Actylis, 4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 9 BASF, 10 Corel Pharma Chem, 2 DFE Pharma, 1 Esteem Industries, 1 Finar, 6 Gangwal Chemicals, 4 Ideal Cures, 1 Ingredion Pharma Solutions, 11 Kerry, 1 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 10 Microlex e.U, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 1 Novo Excipients, 1 Pharmatrans-Sanaq, 2 Pluviaendo, 2 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 21 Roquette, 6 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 8 Sigachi Industries, 2 Silverline Chemicals, 2 The Dow Chemical Company, 2 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

41 Fillers, Diluents & Binders, 41 Coating Systems & Additives, 18 Direct Compression, 18 Controlled & Modified Release, 17 Taste Masking, 17 Thickeners and Stabilizers, 17 Chewable & Orodispersible Aids, 13 Film Formers & Plasticizers, 11 Granulation, 10 Lubricants & Glidants, 9 Co-Processed Excipients, 9 Disintegrants & Superdisintegrants, 8 Topical, 6 Solubilizers, 6 Parenteral, 5 Empty Capsules, 4 Vegetarian Capsules, 4 API Stability Enhancers, 4 Coloring Agents, 4 Emulsifying Agents, 4 Rheology Modifiers, 1 Soft Gelatin

41 Fillers, Diluents & Binders
41 Coating Systems & Additives
18 Direct Compression
18 Controlled & Modified Release
17 Taste Masking
17 Thickeners and Stabilizers
17 Chewable & Orodispersible Aids
13 Film Formers & Plasticizers
11 Granulation
10 Lubricants & Glidants
9 Co-Processed Excipients
9 Disintegrants & Superdisintegrants
8 Topical
6 Solubilizers
6 Parenteral
5 Empty Capsules
4 Vegetarian Capsules
4 API Stability Enhancers
4 Coloring Agents
4 Emulsifying Agents
4 Rheology Modifiers
1 Soft Gelatin

DIGITAL CONTENT

19 News #PharmaBuzz

19 News #PharmaBuzz

GLOBAL SALES INFORMATION

5 US Medicaid Prescriptions, 26 Regulatory FDF Prices, 2 Annual Reports

5 US Medicaid Prescriptions
26 Regulatory FDF Prices
2 Annual Reports

MARKET PLACE

13 APIs

13 APIs

PATENTS & EXCLUSIVITIES

5 US Patents, 6 Health Canada Patents

5 US Patents
6 Health Canada Patents

REF. STANDARDS & IMPURITIES

13 Others

13 Others

ANALYTICAL

2 BioAnalytical Methods

2 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 1,535 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

6 All

01 5Bayer Inc.

02 1Bayer Inc., Healthcare Division

filter Patent Reset all filters

6 All

01 42309332

02 12599617

03 12805600

filter Product Reset all filters

6 All

01 6Vardenafil Hydrochloride

filter Dosage Reset all filters

6 All

01 3Disintegrating Tablet

02 3Tablet

filter Exp Date Reset all filters

6 All

01 42018-10-31

02 12023-07-03

03 12026-02-16

Product Main Page

01

Bayer Inc., Healthcare Division

Vardenafil Hydrochloride

PackExpo

Not Confirmed

Bayer Inc., Healthcare Division

PackExpo

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2018-10-31

Date Granted : 2002-12-03

Vardenafil Hydrochloride

Brand Name : LEVITRA

Patent Number : 2309332

Filing Date : 1998-10-31

Strength per Unit : 5 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2018-10-31

Date Granted : 2002-12-03

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Bayer Inc.

Vardenafil Hydrochloride

PackExpo

Not Confirmed

Bayer Inc.

PackExpo

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2018-10-31

Date Granted : 2002-12-03

Vardenafil Hydrochloride

Brand Name : LEVITRA

Patent Number : 2309332

Filing Date : 1998-10-31

Strength per Unit : 10 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2018-10-31

Date Granted : 2002-12-03

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

Bayer Inc.

Vardenafil Hydrochloride

PackExpo

Not Confirmed

Bayer Inc.

PackExpo

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2018-10-31

Date Granted : 2002-12-03

Vardenafil Hydrochloride

Brand Name : LEVITRA

Patent Number : 2309332

Filing Date : 1998-10-31

Strength per Unit : 20 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2018-10-31

Date Granted : 2002-12-03

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

Bayer Inc.

Vardenafil Hydrochloride

PackExpo

Not Confirmed

Bayer Inc.

PackExpo

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2018-10-31

Date Granted : 2002-12-03

Vardenafil Hydrochloride

Brand Name : STAXYN

Patent Number : 2309332

Filing Date : 1998-10-31

Strength per Unit : 10 mg

Dosage Form : Disintegrating Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2018-10-31

Date Granted : 2002-12-03

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

Bayer Inc.

Vardenafil Hydrochloride

PackExpo

Not Confirmed

Bayer Inc.

PackExpo

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-02-16

Date Granted : 2012-01-10

Vardenafil Hydrochloride

Brand Name : STAXYN

Patent Number : 2599617

Filing Date : 2006-02-16

Strength per Unit : 10 mg

Dosage Form : Disintegrating Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2026-02-16

Date Granted : 2012-01-10

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

Bayer Inc.

Vardenafil Hydrochloride

PackExpo

Not Confirmed

Bayer Inc.

Country

PackExpo

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2023-07-03

Date Granted : 2018-12-18

Vardenafil Hydrochloride

Brand Name : STAXYN

Patent Number : 2805600

Filing Date : 2003-07-03

Strength per Unit : 10 mg

Dosage Form : Disintegrating Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2023-07-03

Date Granted : 2018-12-18

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!